source
- Experts urge cultural shift and standards to unlock real-world evidence potential in medtechAt The MedTech Conference in Boston, experts highlighted the need for a cultural shift to build trust between regulators and medtech firms when using real-world evidence (RWE) for device marketing.…
- Gilead shops in IL-23, inking $1.3B upfront I&I deal with China’s PepStarGilead Sciences has picked up a new inflammatory disease program from China’s PepStar Therapeutics to pair with the Phase 2 inflammatory bowel disease asset emvistegrast.BioSpace · 19d ago↗ source
- FDA uncages Aardvark’s Prader-Willi study after new data cleared safety concerns